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Abstract
Background: The plasma membrane redox system (PMRS) has extensively been studied in erythrocytes. The PMRS
plays an important role in maintaining plasma redox balance and provides a protective mechanism against
oxidative stress. Earlier it was proposed that only NADH or NADPH provided reducing equivalents to PMRS;
however, now it is acknowledged that some polyphenols also have the ability to donate reducing equivalents to
PMRS.
Methods: Two different docking simulation softwares, Molegro Virtual Docker and Glide were used to study the
interaction of certain plant polyphenols viz. quercetin, epigallocatechin gallate, catechin epicatechin and resveratrol
with human erythroyte NADH-cytochrome b5 reductase, which is a component of PMRS and together with the
identification of minimum pharmacophoric feature using Pharmagist.
Results: The derived common minimum pharmacophoric features show the presence of minimum bioactive
component in all the selected polyphenols. Our results confirm wet lab findings which show that these
polyphenols have the ability to interact and donate protons to the Human NADH-cytochrome b5 reductase.
Conclusion: With the help of these comparative results of docking simulation and pharmacophoric features, novel
potent molecules can be designed with higher efficacy for activation of the PMRS system.
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Background
The property of erythrocytes to reduce membrane imper-
meant anions was first reported by Orringer and Roer [1].
Later researches established the existence of trans-mem-
branous NADH dehydrogenases in several other cell
types [2,3]. Evidence is now clear for the presence of a
trans-plasma membrane electron transport or plasma
membrane redox system (PMRS) in all organisms includ-
ing bacteria, yeast, animals and plants [4,5]. It is accepted
that PMRS is involved in transferring reducing equiva-
lents from intracellular donors to extracellular acceptors
mainly oxidized ascorbate. In this way the PMRS helps
the cells to respond to changes in redox potential thereby
regulating a variety of physiological functions including
cell metabolism, ion channels, growth and death [6,7].
The PMRS has extensively been studied in erythrocytes
basically due to the fact that erythrocytes lack mitochon-
dria and PMRS is the only mechanism for trans-plasma
membrane electron transport. Importantly, erythrocytes
encounter a variety of oxidants in the blood during their
life span. Recent reports show that erythrocyte PMRS
plays an important role in providing protection against
oxidative stress during human aging [8,9] and in type 2
diabetes mellitus [10]. The basic structure of PMRS
includes three major entities: the intracellular electron
donor species, electron carrier proteins and oxidoreduc-
tases and extracellular electron acceptors. An important
enzyme of PMRS in erythrocyte is the cytochrome b5
reductase (EC 1.6.2.2).
Cytochrome b5 reductase is encoded by the CYB5R3
locus located on chromosome 22q 13-qter (287). The
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by X-ray crystallography shows similarity with other fla-
vin-linked oxido reductases such as ferredoxin: NADP
+reductase and phthalate dioxygenase reductase [11].
Cyt b5 reductase contains two functional lobes: a flavin
adenine dinuceotide FAD-binding amino terminal
domain (residues 33-147) and NADH-binding carboxyl
end domain (residues 148-170). The two domains are
linked by a hinge region (residues 148-170), which is
critical for the protein conformation and enzymatic
activity. Cyt b5 red. catalyses one-electron reduction
reactions in association with FAD and cytochrome b5.
In erythrocytes, cytochrome b5 reductase primarily
helps in maintaining hemoglobin in its reduced state
Figure 1 2-D structure of selected polyphenols (quercetin, catechin, epicatechin, resveratrol and EGCG), FAD, beta-NADH and NADPH.
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Page 2 of 11and also plays a crucial role in reducing extracellular
ascorbate-free radical to ascorbate. Earlier it was pro-
posed that only NADH or NADPH provided reducing
equivalents to PMRS, however, now it is acknowledged
that some polyphenols and ascorbate also have the abil-
ity to donate reducing equivalents to PMRS. It is now
known that resveratrol, quercetin, myricetin, and epigal-
locatechin gallate (EGCG) may be taken up by erythro-
cytes from the plasma and actively promote PMRS
activity [12,13]. In view of the important role of PMRS
during aging and the emerging opinion that activation
of erythrocyte PMRS may be an effective anti-aging
strategy [14], this study was undertaken to determine
the comparative molecular binding indices of some
polyphenols (quercetin, catechin, epicatechin, resveratrol
and EGCG together with FAD, NADPH and NADH
(Figure 1) with an important component of erythrocyte
PMRS, the cytochrome b5 reductase, through computa-
tional docking simulation using Molegro Virtual Docker
(MVD) [15], Glide module (supplied by Schrödinger
suite) [16] and ligand-based pharmacophoric feature
derivation using PharmaGist server [17].
Methods
Protein structure and preparation
Three-dimensional X-ray crystallized structure of
Human NADH-cytochrome b5 reductase (PDB:
1UMK, resolution = 1.75 Å) was downloaded from the
Protein Data Bank [18,19]. The downloaded protein
has single chain A with 275 residues together with
FAD-binding region and contains bound FAD as a
ligand molecule. It also contains 753 water molecules
of crystallization. The protein structure was prepared
using the protein preparation module of Schrödinger
software [20]. The co-crystallized ligands and water
molecules were removed. Some residues and side chain
atom are missing in crystallized structure of protein
that was modeled using Prime 2.2.108 followed by
refinement of the protein structure. The final modeled
protein was taken as receptor protein and found the
most suitable-binding site using sitemap script of
Schrödinger. On the basis of priority of site, FAD-
binding site has been selected for docking with the
FAD, NADPH, beta-NADH, catechin, quercetin, epica-
techin, EGCG and resveratrol.
Ligands structure preparation
All the selected ligands were assigned an appropriate
bond order using the LigPrep 2.4.107 script and con-
verted to .mae format (Maestro, Schrödinger, Inc.) fol-
lowed by optimization by means of the OPLS_2005
force field [21].
Experimental
Docking study with MVD
It is an automated docking software with fast processing.
The preparation of selected polyphenols and protein
were done using default parameters, which automatically
adds the missing hydrogen atoms. The software has mod-
ule to create surface over receptor molecule and to give
possible binding site for its activity. The active site region
of receptor Human NADH-cytochrome b5 reductase
protein was chosen for docking, which is already known
from literature with the selected polyphenols. It gives ten
conformations for each ligand and returns five outputs
with MoleDockScore and other thermodynamically cal-
culated values. The MoleDockScore is an anonymous
value on which we have to suggest the best docked ligand
with its conformation. It also shows hydrogen bond
information together with other thermodynamic values,
which suggest the formation of stable complex between
ligand and receptor molecule [15].
Table 1 Comparative docking simulation result of
selected polyphenols, NADPH and beta-NADH with
Human NADH-cytochrome b5 reductase together with
FAD, ligand from X-ray Crystallized data of protein data
bank (1umk.pdb) using MVD
Serial Number Ligands MoleDockScore H-bonding energy
1. FAD -232.638 -20.532
2. NADPH -209.954 -13.985
3. beta-NADH -208.235 -13.506
4. EGCG -131.595 -9.012
5. Quercetin -113.611 -10.033
6. Catechin -110.472 -9.063
7. Epicatechin -102.952 -14.638
8. Resveratrol -102.074 -10.272
Table 2 Comparative docking simulation result of
selected polyphenols, FAD, NADPH and beta-NADH with
Human NADH-cytochrome b5 reductase using Glide
docking simulation software
Serial
number
Ligands GScore Lipophilic
EvdW
HBond Electro
1 FAD -12.18 -5.07 -2.14 -0.71
2 NADPH -10.86 -4.45 -2.13 -0.68
3 beta-NADH -10.48 -4.43 -1.72 -0.79
4 EGCG -9.10 -4.13 -1.33 -0.51
5 Catechin -7.83 -4.41 -1.75 -0.95
6 Quercetin -7.82 -4.19 -1.58 -0.94
7 Epicatechin -7.57 -3.12 -1.33 -1.07
8 Resveratrol -4.29 -3.8 -1.5 -0.54
Where GScore: It is GlideScore called as Docking Score
LipophilicEvdW: It is term derived from hydrophobic grid potential and fraction
of the total protein-ligand Van der Waals energy; HBond: Hydrogen-bonding
term.
Electro: This term represents Electrostatic rewards
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The Protein ligand docking studies were performed
using Maestro 9.1.107. Default parameters were selected
with Glide Extra Precision (XP Glide), version 4.5.19.
After the complete preparation of ligands and protein
for docking, receptor-grid files were generated. For run-
ning the grid generation module we have scaled van der
Waal radii of receptor atoms by 1.00 Å with a partial
atomic charge of 0.25. A grid box of size 25 × 25 × 25
Å with coordinates X = 37.955433, Y = -6.749032 and Z
= 39.920372 was generated at the centroid of the FAD-
binding site predicted by sitemap script of Schrödinger
suite 10.0. After the formation of receptor-grid file, flex-
ible ligands with rigid receptor docking were performed.
Glide generates conformations internally and passes
these through a series of filters. The final energy evalua-
tion is done with GlideScore and a single best pose is
generated as the output for a particular ligand [16].
Pharmacophoric study
It is highly efficient method for the derivation of a mini-
mum pharmacophoric features which is spatial arrange-
ment of physico-chemical properties in a set of ligand,
essential for the interaction with a specific receptor. It
takes three dimensional structure of set of ligands as an
input to multiply align flexible ligands in a deterministic
manner and to focus on the input ligands. It searches
shared large common substructure for the detection of
both outer molecules and alternative binding modes and
finally derived pharmacophoric features shared by a
large number of ligand molecules as an output [17].
Results and discussion
The binding site cavity detection and docking simulation
was performed by using two different docking softwares,
namely MVD and Glide simulation module (supplied by
Schrödinger suite) for the selected polyphenols together
with FAD NADPH and beta-NADH at Human NADH-
cytochrome b5 reductase.
The results obtained using MVD and Glide, shown in
terms of MoleDockScore; H-bonding energy and Glide
score; LipophilicEvdW enrgy; HBond energy; Electro
energy respectively are given in Table 1 and 2.
The comparative result of docking simulation given in
Tables 3 and 4, shows active site residues and proves
Table 3 Human NADH-cytochrome b5 reductase protein residues interact with selected polyphenols, NADPH and beta-
NADH using MVD (highlighted residues are involved in H-bonding interaction with ligands) and FAD from X-ray
Crystallized data of protein data bank
Serial
Number.
ligands Interacting residues of receptor Human NADH-cytochrome b5 reductase No. of H-bond
interaction
1. FAD Arg91, Pro92, Tyr93, Val108, Ile109, Lys110, Tyr112, Phe113, Phe120, Gly123, Gly124, Lys125,
Ser127, Thr181, Thr184
13
2. NADPH His77, Arg91, Pro92, Tyr93, Thr94, Val108, Ile109, Try112, His117, Phe120, Gly123, Ser127, Thr181,
Thr184, Pro185
12
3. beta-NADH Arg91, Pro92, Tyr93, Thr94, Val108, Ile109, Lys110, Phe113, His117, Gly123, Gly124, Lys125,
Thr181, Thr184
10
4. EGCG Arg91, Tyr93, Tyr112, Phe113, His17, Phe120, Gly123, Gly124, Lys125 5
5. Catechin His77, Pro92, Tyr93, Thr94, Val108, Ile109, Thr184, Pro185, Phe300 6
6. Quercetin His77, Pro92, Tyr93, Thr94, Val108, Ile109, Thr181, Thr184, Cys273, Phe300 7
7. Epicatechin Pro92, Tyr93, Thr94, Val108, Ile109, Lys110, Thr181, Thr184, Pro185, Phe300 8
8. Resveratrol His77, Pro92, Tyr93, Thr94, Val108, Ile109, Lys110, Thr181, Thr184, Pro185, Phe300 5
Where MoleDock Score is molegro docking scoring function or Energy Score (EScore)
Table 4 Human NADH-cytochrome b5 reductase protein residues interact with selected polyphenols, NADPH, beta-
NADH using Glide docking simulation software (highlighted residues are H-bonding interacting residues) and FAD
from X-ray Crystallized data of protein data bank
S.
No.
ligands Interacting residues of receptor Human NADH-cytochrome b5 reductase No. of H-bond
interaction
1. FAD Arg91, Pro92, Tyr93, Thr94, Val108, Ile109, Lys110, Phe113, Phe120, Gly123, Gly124, Lys125, Met126,
Ser127, Gly179, Gly180, Thr181, Thr184
17
2. NADPH Thr94, Lys110, Try112, His117, Gly179, Gly180, Thr181, Thr184, Gln210, Cys273, Pro275 8
3. beta-NADH Tyr93, Lys110, Tyr112, Gly179, Gly180, Thr181, Gln210, Asp239, Phe251, Val252, Pro275 8
4. EGCG His117, Asn209, Gln210, Asp239, Phe251, Met278 4
5. Catechin Lys110, Tyr112, Gly180, Ala208, Asn209, Gln210, Phe251, Val252, Pro275 6
6. Quarcetin Lys110, Tyr112, Ala208, Asn209, Asp239, Phe251 4
7. Epicatechin Lys110, Tyr112, Gly180, Ala208, Gln210, Asp239, Phe251, Val252, Pro275 7
8. Reserveratrol Lys110, Tyr112, Ala208, Gln210, Phe251, Val252 3
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action between selected polyphenols, FAD, NADPH and
beta-NADH with the receptor Human NADH-cyto-
chrome b5 reductase.
The binding affinity of selected polyphenols, NADPH,
beta-NADH and FAD at the active site of Human
NADH-cytochrome b5 reductase using MVD and Glide
in decreasing order is: FAD>NADPH>beta-
Figure 2 Secondary structure (cartoon) representation of the active site of receptor human NADH-cytochrome b5 reducatse protein
with docked conformation of selected ligand molecules NADPH, beta-NADH, EGCG, quercetin, catechin, epicatechin, resveratrol
together with FAD (ligand from crystal structure of 1umk.pdb) using Glide.
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trol and FAD>NADPH>beta-NADH>FAD>NADPH>-
beta-NADH>EGCG>catechin>quercetin>epicatechin>-
resveratrol respectively.
The Figure 2 of Glide docking simulation results
shows low energy bound conformation of selected poly-
phenols, NADPH, beta-NADH and together with FAD
(ligand from crystal structure of PDB:1UMK) at the
active site of Human NADH-cytochrome b5 reductase.
The low energy bound conformation of selected ligands
shows hydrogen bonding and electrostatic interactions
as shown in Figure 3 (a, b), 4 (a, b), 5 (a, b), 6(a, b), 7
(a, b), 8(a, b), 9 (a, b) and 10(a, b) for FAD, NADPH,
beta-NADH, epigallocatechin gallate, catechin, quarce-
tin, epicatechin and resveratrol respectively.
Figure 2 of Glide docking simulation results shows
low energy bound conformation of selected polyphenols,
NADPH, beta-NADH, and together with FAD (ligand
from crystal structure of PDB : 1 U M K )a tt h ea c t i v es i t e
of Human NADH-cytochrome b5 reductase. The low
energy bound conformation of selected ligands shows
hydrogen bonding and electrostatic interactions as
s h o w ni nF i g u r e s3 a ,b ,4 a ,b ,5 a ,b ,6 a ,b ,7 a ,b ,8 a ,b ,
9a, b, and 10a, b for FAD, NADPH, beta-NADH,
EGCG, catechin, quarcetin, epicatechin, and resveratrol,
respectively
Computational methods provide aids for not only
designing and interpretation of hypothesis-driven experi-
ments in the field of drug discovery research but may
also be used to compare in vitro results for rapid gen-
eration of new hypotheses. The binding affinity was
higher for FAD because it is a natural ligand of the
receptor protein having highest number of hydrogen
bonds. The formation of hydrogen bonds provides addi-
tional force to stabilize the ligand-protein complex
required for the activity of the Human NADH-cyto-
chrome b5 reductase. The results obtained using two
different docking simulation softwares were compared
and their findings were common, which also strongly
supports our in silico findings. An analysis of pharmaco-
phoric features of the docked conformation for all the
selected polyphenols, NADPH, beta-NADH and FAD, in
the study provided the minimum common phormaco-
p h o r i cf e a t u r e ss h o w ni nF i g ure 11, which include one
aromatic ring, two donor atoms and one acceptor atom
derived from PhrmaGist server [17]. The presence of
Figure 3 Docked conformation of hydrogen bonding view and 3.b with Electrostatic interaction of FAD with interacting amino acids
of human NADH-cytochrome b5 reducatse protein at the active site cavity.
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Page 6 of 11Figure 4 Docked conformation of hydrogen bonding view and 4.b with Electrostatic interaction of NADPH with interacting amino
acids of human NADH-cytochrome b5 reducatse protein at the active site cavity.
Figure 5 Docked conformation of hydrogen bonding view and 5.b with Electrostatic interaction of beta-NADH with interacting amino
acids of human NADH-cytochrome b5 reducatse protein at the active site cavity.
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Page 7 of 11Figure 6 Docked conformation of hydrogen bonding view and 6.b, Electrostatic interaction of EGCG with interacting amino acids of
human NADH-cytochrome b5 reducatse protein at the active site cavity.
Figure 7 Docked conformation of hydrogen bonding view and 7.b with Electrostatic interaction of Catechin with interacting amino
acids of human NADH-cytochrome b5 reducatse protein at the active site cavity.
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Page 8 of 11Figure 8 Docked conformation of hydrogen bonding view and 8.b with Electrostatic interaction of Quercetin with interacting amino
acids of human NADH-cytochrome b5 reducatse protein at the active site cavity.
Figure 9 Docked conformation of hydrogen bonding view and 9.b with Electrostatic interaction of Epicatechin with interacting amino
acids of human NADH-cytochrome b5 reducatse protein at the active site cavity.
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selected polyphenols proves the wet lab findings [12,13]
which show that these polyphenols have the ability to
interact and donate protons to the Human NADH-cyto-
chrome b5 reductase.
Conclusion
Given the importance of human PMRS system during
human aging and life span determination [8,9,22], our
findings provide important insight into the docking and
binding characteristics of the selected polyphenols on
the Human NADH-cytochrome b5 reductase. With the
help of these comparative results for docking simulation
and pharmacophoric features, molecules having higher
electron donor/acceptor efficacy for activation of the
PMRS system can be designed. It is significant that acti-
vation of PMRS is being viewed as a putative mechan-
ism for designing anti-aging agents [14]. Our in silico
study may also lead to important information regarding
the use of polyphenols as immunomodulating agents.
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